NEPH

NEPHROS INC NEPH

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #1,569 of 2,925

Why it scores 51Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$6.02M

Quarter to Jun 30

Net income

$1.20M

Quarter to Jun 30

Operating margin

20.2%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$18.97M total
WEXFORD CAPITAL LP
$12.85M0.0%
Topline Capital Management, LLC
$1.91M-8.0%
VANGUARD CAPITAL MANAGEMENT LLC
$709.2K0.0%
MORGAN STANLEY
$460.2K+16.2%
Cornerstone Capital, Inc.
$459.5K0.0%
BARD ASSOCIATES INC
$421.3K-2.6%
RENAISSANCE TECHNOLOGIES LLC
$276.7K-22.0%
GEODE CAPITAL MANAGEMENT, LLC
$250.9K-3.7%
Mesirow Financial Investment Management, Inc.
$214.2K-50.0%
HighTower Advisors, LLC
$213.2K0.0%
NAVELLIER & ASSOCIATES INC
$190.9K+179.6%
ESSEX INVESTMENT MANAGEMENT CO LLC
$139.0K-0.1%
VANGUARD FIDUCIARY TRUST CO
$131.7K0.0%
BLAIR WILLIAM & CO/IL
$129.4K0.0%
CITADEL ADVISORS LLC
$103.7K+39.0%
DIMENSIONAL FUND ADVISORS LP
$79.1K+6.8%
BlackRock, Inc.
$67.2KNew
De Lisle Partners LLP
$62.1K-30.4%
NORTHERN TRUST CORP
$59.6K+54.3%
STATE STREET CORP
$56.0K0.0%
GOLDMAN SACHS GROUP INC
$45.8K-9.4%
MERCER GLOBAL ADVISORS INC /ADV
$44.6KNew
Spears Abacus Advisors LLC
$39.3K0.0%
ELKHORN PARTNERS LIMITED PARTNERSHIP
$39.3K-8.3%
ROYAL BANK OF CANADA
$3.0K+10.7%
See all 33 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Operating Margin

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/NEPH

Earnings Per Share

13fpro.ai/company/NEPH

Loading ratio trend…

NEPH key financials by period

Reported revenue, net income and operating margin by fiscal year, from NEPHROS INC's annual filings on SEC EDGAR.

NEPHROS INC reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$18.8M$1.2M6.1%
FY 2024$14.2M$74.0K0.0%
FY 2023$14.2M$-1.6M-11.2%
FY 2022$10.0M$-7.1M-43.5%
FY 2021$10.2M$-3.9M-31.8%
FY 2020$8.6M$-4.5M-49.9%
Source: NEPH filings on SEC EDGAR →

NEPH insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About NEPHROS INC (NEPH): stock profile, AI score and financials

NEPHROS INC (NEPH) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NEPH at 51.2/100 on a composite quality score built from its SEC filings, placing it at rank #1,569 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), NEPHROS INC reports quarterly revenue of $6.0M, net income of $1.2M, an operating margin of 20.2%. Top institutional holders of NEPH by reported 13-F value include WEXFORD CAPITAL, Topline Capital Management, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. NEPH trades on the Nasdaq exchange and files with the SEC under CIK 1196298. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NEPH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NEPHROS INC directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1196298 →